rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kathleen Borthwick

CFO

Company insider

Files Form 4 as: CFO, Passage Bio.

Every Form 4 they filed

In numbers

Trades disclosed
21
Buys
0
Sells
4
Bought
$0
Sold
$89K
Companies
1
Companies where not an officer
0
First trade
28 Jul 2023
Last trade
16 Mar 2026
Last filed
18 Mar 2026

Companies traded

Where they are an officer
PASG Passage BioOfficer · Biotechnology · last 16 Mar 20260 buys · 4 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Mar 2026filed 18 Mar 2026PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—15,610 at $0.00filing
16 Mar 2026filed 18 Mar 2026PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—15,610 at $0.00filing
8 Jan 2026filed 12 Jan 2026PASG Passage BioBiotechnologySEC FORM 4 Code M—5,000filing
8 Jan 2026filed 12 Jan 2026PASG Passage BioBiotechnologySEC FORM 4 Sold$38K2,062 at $18.44filing
8 Jan 2026filed 12 Jan 2026PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code M—5,000 at $0.00filing
8 Jan 2026filed 12 Jan 2026PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code M—5,000 at $0.00filing
8 Jan 2026filed 12 Jan 2026PASG Passage BioBiotechnologySEC FORM 4 Code M—5,000filing
8 Jan 2026filed 12 Jan 2026PASG Passage BioBiotechnologySEC FORM 4 Sold$38K2,062 at $18.44filing
15 Mar 2025filed 18 Mar 2025PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—278,386 at $0.00filing
11 Feb 2025filed 12 Feb 2025PASG Passage BioBiotechnologySEC FORM 4 Sold$1,6873,183 at $0.53filing
10 Feb 2025filed 12 Feb 2025PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code M—8,000 at $0.00filing
10 Feb 2025filed 12 Feb 2025PASG Passage BioBiotechnologySEC FORM 4 Code M—8,000filing
15 Jan 2025filed 29 Dec 2025PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
15 Mar 2024filed 19 Mar 2024PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—227,000 at $0.00filing
13 Feb 2024filed 13 Feb 2024PASG Passage BioBiotechnologySEC FORM 4 Sold$1,4261,470 at $0.97filing
10 Feb 2024filed 13 Feb 2024PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code M—4,000 at $0.00filing
10 Feb 2024filed 13 Feb 2024PASG Passage BioBiotechnologySEC FORM 4 Code M—4,000filing
2 Jan 2024filed 3 Jan 2024PASG Passage BioBiotechnologySEC FORM 4 Sold$9,71210,672 at $0.91filing
31 Dec 2023filed 3 Jan 2024PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code M—30,000 at $0.00filing
31 Dec 2023filed 3 Jan 2024PASG Passage BioBiotechnologySEC FORM 4 Code M—30,000filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

Weston NicholsDirector · 10% owner at Passage BIO, filing Form 4 there in the last year
Lynx1 Capital Management LP10% owner · 10% owner at Passage BIO, filing Form 4 there in the last year
Athena CountouriotisDirector · Director at Passage BIO, filing Form 4 there in the last year
Sandip KapadiaDirector · Director at Passage BIO, filing Form 4 there in the last year
Derrell PorterDirector · Director at Passage BIO, filing Form 4 there in the last year